Alkem MedTech, the medical devices arm of Alkem Laboratories, has moved to acquire a controlling stake in Swiss cardiac device maker Occlutech Holding AG by signing a binding agreement to purchase up to 55 % of the company for €99.4 million (approximately ₹1,074 crore).
The transaction remains subject to customary regulatory and statutory approvals and is expected to close by June 2026.
The acquisition marks Alkem MedTech’s entry into the global structural heart devices market and significantly expands its footprint beyond its…
